1
|
Tong SY, Ye K, Wang WX, Ai HL. Harzianic acids and oxazolidinone from the endophytic fungus Ilyonectria sp. and their cytotoxicity activity. Fitoterapia 2024; 175:105941. [PMID: 38575089 DOI: 10.1016/j.fitote.2024.105941] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2023] [Revised: 03/08/2024] [Accepted: 04/01/2024] [Indexed: 04/06/2024]
Abstract
Four undescribed compounds including three harzianic acids (1, 3 and 4) and one oxazolidinone (2), along with three known ones (5-7) were isolated from the solid fermented product of endophytic fungus Ilyonectria sp., their structures were elucidated as 1-amino-harzianic acid (1), ilyonectria-oxazolidinone (2),10'-nor- isoharzianic acid (3), isohomoharzianic acid (4), harzianic acid (5), isoharzianic acid (6), homoharzianic acid (7) by means of detailed chemical evidences and spectroscopic data analysis. All the compounds were evaluated for cytotoxicity against SMMC-7721 human cancer cell lines by MTS assay. Among the seven tested compounds, 1-amino-harzianic acid (1) demonstrated well cytotoxic activity against SMMC-7721 with IC50 value of 26.84 μM. The results of molecular docking indicated that compound exhibited moderate anti-tumor activity may through binding to apoptosis related proteins.
Collapse
Affiliation(s)
- Shun-Yao Tong
- School of Pharmaceutical Science, South-Central Minzu University, Wuhan, Hubei 430074, China
| | - Ke Ye
- School of Pharmaceutical Science, South-Central Minzu University, Wuhan, Hubei 430074, China
| | - Wen-Xiang Wang
- School of Pharmacy, Chongqing Three Gorges Medical College, Chongqing 404120, China.
| | - Hong-Lian Ai
- School of Pharmaceutical Science, South-Central Minzu University, Wuhan, Hubei 430074, China.
| |
Collapse
|
2
|
Shao F, Shen Q, Yang Z, Yang W, Lu Z, Zheng J, Zhang L, Li H. Research Progress of Natural Active Substances with Immunosuppressive Activity. Molecules 2024; 29:2359. [PMID: 38792220 PMCID: PMC11124018 DOI: 10.3390/molecules29102359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2024] [Revised: 05/14/2024] [Accepted: 05/14/2024] [Indexed: 05/26/2024] Open
Abstract
The increasing prevalence of autoimmune diseases globally has prompted extensive research and the development of immunosuppressants. Currently, immunosuppressive drugs such as cyclosporine, rapamycin, and tacrolimus have been utilized in clinical practice. However, long-term use of these drugs may lead to a series of adverse effects. Therefore, there is an urgent need to explore novel drug candidates for treating autoimmune diseases. This review aims to find potential candidate molecules for natural immunosuppressive compounds derived from plants, animals, and fungi over the past decade. These compounds include terpenoids, alkaloids, phenolic compounds, flavonoids, and others. Among them, compounds 49, 151, 173, 200, 204, and 247 have excellent activity; their IC50 were less than 1 μM. A total of 109 compounds have good immunosuppressive activity, with IC50 ranging from 1 to 10 μM. These active compounds have high medicinal potential. The names, sources, structures, immunosuppressive activity, and the structure-activity relationship were summarized and analyzed.
Collapse
Affiliation(s)
- Fei Shao
- School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China; (F.S.)
| | - Qiying Shen
- School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China; (F.S.)
| | - Zhengfei Yang
- School of Traditional Chinese Medicine, Ningxia Medical University, Yinchuan 750004, China
| | - Wenqian Yang
- School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China; (F.S.)
| | - Zixiang Lu
- School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China; (F.S.)
| | - Jie Zheng
- School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China; (F.S.)
| | - Liming Zhang
- School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China; (F.S.)
| | - Hangying Li
- School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China; (F.S.)
- Key Laboratory of Craniocerebral Diseases, Ningxia Medical University, Yinchuan 750004, China
| |
Collapse
|
3
|
Kuang M, Peng WW, Huang YT, Li MF, Qin SY, Zheng YT, Xu L, Huang Q, Zou ZX. Two new chromone derivatives from the rhizosphere soil fungus Ilyonectria robusta. Nat Prod Res 2024; 38:1398-1405. [PMID: 36408983 DOI: 10.1080/14786419.2022.2147169] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2022] [Revised: 10/29/2022] [Accepted: 11/07/2022] [Indexed: 11/23/2022]
Abstract
Two new chromone derivatives (1 and 2), and two known compounds (3 and 4) were isolated from the rhizosphere soil fungus Ilyonectria robusta. Their planar structures and absolute configurations were determined by extensive spectroscopic analysis and electronic circular dichroism (ECD) calculations. Additionally, all the isolated compounds were evaluated for their antibacterial activity against Staphylococcus aureus, Enterococcus faecalis, Pseudomonas aeruginosa and Escherichia coli, but no obvious activity was observed at a concentration of 128 μg/mL.
Collapse
Affiliation(s)
- Min Kuang
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, P.R. China
- Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha, P.R. China
| | - Wei-Wei Peng
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, P.R. China
- Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha, P.R. China
| | - Yuan-Tao Huang
- Affiliated Haikou Hospital of Xiangya School of Medicine, Central South University, Haikou, P.R. China
| | - Mei-Fang Li
- Affiliated Haikou Hospital of Xiangya School of Medicine, Central South University, Haikou, P.R. China
| | - Si-Yu Qin
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, P.R. China
- Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha, P.R. China
| | - Yu-Ting Zheng
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, P.R. China
- Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha, P.R. China
| | - Li Xu
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, P.R. China
- Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha, P.R. China
| | - Qi Huang
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, P.R. China
- Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha, P.R. China
- Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, P.R. China
| | - Zhen-Xing Zou
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, P.R. China
- Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha, P.R. China
| |
Collapse
|
4
|
Gupta A, Meshram V, Gupta M, Goyal S, Qureshi KA, Jaremko M, Shukla KK. Fungal Endophytes: Microfactories of Novel Bioactive Compounds with Therapeutic Interventions; A Comprehensive Review on the Biotechnological Developments in the Field of Fungal Endophytic Biology over the Last Decade. Biomolecules 2023; 13:1038. [PMID: 37509074 PMCID: PMC10377637 DOI: 10.3390/biom13071038] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2023] [Revised: 06/14/2023] [Accepted: 06/15/2023] [Indexed: 07/30/2023] Open
Abstract
The seminal discovery of paclitaxel from endophytic fungus Taxomyces andreanae was a milestone in recognizing the immense potential of endophytic fungi as prolific producers of bioactive secondary metabolites of use in medicine, agriculture, and food industries. Following the discovery of paclitaxel, the research community has intensified efforts to harness endophytic fungi as putative producers of lead molecules with anticancer, anti-inflammatory, antimicrobial, antioxidant, cardio-protective, and immunomodulatory properties. Endophytic fungi have been a valuable source of bioactive compounds over the last three decades. Compounds such as taxol, podophyllotoxin, huperzine, camptothecin, and resveratrol have been effectively isolated and characterized after extraction from endophytic fungi. These findings have expanded the applications of endophytic fungi in medicine and related fields. In the present review, we systematically compile and analyze several important compounds derived from endophytic fungi, encompassing the period from 2011 to 2022. Our systematic approach focuses on elucidating the origins of endophytic fungi, exploring the structural diversity and biological activities exhibited by these compounds, and giving special emphasis to the pharmacological activities and mechanism of action of certain compounds. We highlight the tremendous potential of endophytic fungi as alternate sources of bioactive metabolites, with implications for combating major global diseases. This underscores the significant role that fungi can play in the discovery and development of novel therapeutic agents that address the challenges posed by prevalent diseases worldwide.
Collapse
Affiliation(s)
- Aditi Gupta
- School of Studies in Biotechnology, Pandit Ravishankar Shukla University, Raipur 492010, Chhattisgarh, India
| | - Vineet Meshram
- School of Studies in Biotechnology, Pandit Ravishankar Shukla University, Raipur 492010, Chhattisgarh, India
| | - Mahiti Gupta
- Department of Biotechnology, Maharishi Markandeshwar (Deemed to be University), Mullana 133207, Haryana, India
| | - Soniya Goyal
- Department of Biotechnology, Maharishi Markandeshwar (Deemed to be University), Mullana 133207, Haryana, India
| | - Kamal Ahmad Qureshi
- Department of Pharmaceutics, Unaizah College of Pharmacy, Qassim University, Unaizah 51911, Saudi Arabia
| | - Mariusz Jaremko
- Smart-Health Initiative (SHI) and Red Sea Research Center (RSRC), Division of Biological and Environmental Sciences and Engineering (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal 23955, Saudi Arabia
| | - Kamlesh Kumar Shukla
- School of Studies in Biotechnology, Pandit Ravishankar Shukla University, Raipur 492010, Chhattisgarh, India
| |
Collapse
|
5
|
Ai HL, Lv X, Ye K, Wang MX, Huang R, Shi BB, Li ZH. Four New Highly Oxygenated Eremophilane Sesquiterpenes from an Endophytic Fungus Boeremia exigua Isolated from Fritillaria hupehensis. J Fungi (Basel) 2022; 8:jof8050492. [PMID: 35628748 PMCID: PMC9146970 DOI: 10.3390/jof8050492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2022] [Revised: 05/03/2022] [Accepted: 05/05/2022] [Indexed: 11/16/2022] Open
Abstract
Four new eremophilane-type sesquiterpenes, boeremialanes A–D (1–4) were obtained from solid substrate cultures of Boeremia exigua (Didymellaceae), an endophytic fungus isolated from Fritillaria hupehensis (Liliaceae). Boeremialanes A–C (1–3) are highly oxygenated eremophilanes with a benzoate unit attached at the C-13 position and are rarely found in nature. Their structures and absolute configurations were determined by extensive spectroscopic methods, electronic circular dichroism (ECD), and nuclear magnetic resonance (NMR) calculations with DP4+ analysis. Boeremialane D (4) potently inhibited nitric oxide production in lipopolysaccharide-treated RAW264.7 macrophages with an IC50 of 8.62 μM and was more potent than the positive control, pyrrolidinedithiocarbamate (IC50 = 23.1 μM).
Collapse
|